Guangdong Provincial Engineering Laboratory of Biomass High Value Utilization, Institute of Biological and Medical Engineering, Guangdong Academy of Sciences, Guangzhou, China.
Experimental Drug Development Centre, Agency for Science, Technology and Research, Singapore, Singapore.
FEBS Lett. 2023 Aug;597(16):2031-2047. doi: 10.1002/1873-3468.14710. Epub 2023 Aug 8.
RNA-binding proteins (RBPs) play vital roles in organisms through binding with RNAs to regulate their functions. Small molecules affecting the function of RBPs have been developed, providing new avenues for drug discovery. Herein, we describe the perspectives on developing small molecule regulators of RBPs. The following types of small molecule modulators are of great interest in drug discovery: small molecules binding to RBPs to affect interactions with RNA molecules, bifunctional molecules binding to RNA or RBP to influence their interactions, and other types of molecules that affect the stability of RNA or RBPs. Moreover, we emphasize that the bifunctional molecules may play important roles in small molecule development to overcome the challenges encountered in the process of drug discovery.
RNA 结合蛋白 (RBPs) 通过与 RNA 结合来调节其功能,在生物体中发挥着重要作用。已经开发出了影响 RBPs 功能的小分子,为药物发现提供了新途径。本文描述了开发 RBP 小分子调节剂的观点。在药物发现中,以下类型的小分子调节剂具有很大的研究价值:与 RBPs 结合以影响与 RNA 分子相互作用的小分子、与 RNA 或 RBP 结合以影响其相互作用的双功能分子,以及影响 RNA 或 RBPs 稳定性的其他类型的分子。此外,我们强调双功能分子可能在小分子开发中发挥重要作用,以克服药物发现过程中遇到的挑战。